Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RenovoRx (RNXT) Liabilities and Shareholders Equity (2024 - 2025)

RenovoRx (RNXT) has disclosed Liabilities and Shareholders Equity for 2 consecutive years, with $8.1 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity changed 0.28% to $8.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.0 million through Dec 2025, up 40.12% year-over-year, with the annual reading at $8.1 million for FY2025, 0.28% changed from the prior year.
  • Liabilities and Shareholders Equity hit $8.1 million in Q4 2025 for RenovoRx, down from $11.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $16.0 million in Q1 2025 to a low of $4.8 million in Q1 2024.